Type 2 Diabetes Trial, Not Yet Recruiting NCT06493955 Sponsor: University Hospital, Bordeaux Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT06493955
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with type 2 diabetes, confirmed by two separate fasting blood sugar readings above 1.26 g/l.
  • People aged 18 or older.
  • People with a Marshall score (a health assessment measure) of 3 or below (confirm with trial site).
  • People who live in the Nouvelle-Aquitaine region of France.
  • People who are eligible for the "Passerelle" program (confirm with trial site for details on what this program involves).
  • People who are willing to take part in the study.
  • People who agree to participate and have signed an informed consent form.
  • People who are covered by, or benefit from, a French social security scheme.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have any other health condition that is not yet stable or well-controlled, including: unstable or stress-related chest pain, severely high blood pressure, a recent heart attack, or other uncontrolled heart conditions; uncontrolled asthma or a flare-up of chronic obstructive pulmonary disease (a serious lung condition); diabetes with an HbA1c (a long-term blood sugar measure) above 9%, or a serious foot condition related to diabetes.
  • People who are pregnant.
  • People with diabetes who have a medical reason why they cannot be prescribed adapted physical activity (APA — a type of supervised exercise program).
  • People who are under legal court protection (a formal arrangement where a court oversees a person's affairs).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 September 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

ONAPS-PAQ questionnaire,

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov